Medtronic Total Cost of Revenue increased by 6.5% to $3.26B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.3%, from $2.78B to $3.26B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 2.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.65B | $2.60B | $2.50B | $2.46B | $2.59B | $2.52B | $2.54B | $2.69B | $2.98B | $2.63B | $2.76B | $2.78B | $3.04B | $2.76B | $2.95B | $2.78B | $3.15B | $3.00B | $3.06B | $3.26B |
| QoQ Change | — | -2.1% | -3.9% | -1.5% | +5.4% | -2.9% | +0.8% | +6.1% | +10.8% | -11.8% | +5.1% | +0.8% | +9.4% | -9.3% | +6.7% | -5.7% | +13.2% | -4.6% | +2.0% | +6.5% |
| YoY Change | — | — | — | — | -2.3% | -3.2% | +1.5% | +9.4% | +15.0% | +4.5% | +8.9% | +3.5% | +2.2% | +5.1% | +6.7% | -0.1% | +3.4% | +8.7% | +3.9% | +17.3% |